Cervical Sliding Sign to Predict Outcome of Induction of Labor (NCT06324279) | Clinical Trial Compass
UnknownNot Applicable
Cervical Sliding Sign to Predict Outcome of Induction of Labor
Egypt130 participantsStarted 2023-09-01
Plain-language summary
Assess the role of transvaginal ultrasound specifically a sign called cervical sliding sign, in the prediction of success of induction of labor.
The prediction of outcome of induction of labor has always been an important topic to all obstetricians. Bishop score is traditionally considered reliable way to predict the outcome of induction of labor by assessing the cervical dilatation, effacement, position, and consistence and assessing the level of the fetal head in the birth canal. Since The bishop score remains a highly subjective method for prediction of outcome of induction of labor, the use of sonographic measurements such as cervical sliding sign can be a better predictor of successful induction of labor.The presence of CSS was defined as the sliding of the anterior cervical lip on the posterior one under gentle pressure of the transvaginal probe.
Patients undergoing induction of labor with misoprostol will be checked for the cervical sliding sign. The mode of delivery, induction to active labor time and active labor to delivery time will be recorded and analysed to assess whether the sliding sign is an independent predictor of success of induction.
Who can participate
Age range
18 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 1\. women age: from 18 to 45 years old.
2\. Single living term fetus with gestational age ≥ 37 weeks.
3- Eligible for IOL. 4- Bishop score \<6 5- Estimated fetal weight \< 4Kg.
Exclusion Criteria:
* 1- previous caesarean section. (increases risk of rupture uterus) 2- Multiple pregnancy, IUFD, preterm or macrosomic fetus (defined as fetus
\>4.5kg or fetus of diabetic mother \>4Kg) (increases risk of shoulder dystocia) 3- Women with major uterine anomalies. (appendix A: ESHRE/ESGE classification for Female genital tract anomalies (Grimbizis GF, et al,. 2013) (increases risk of CS) 4- Vasa previa, placenta previa (increases risk of antepartum hemorrhage) 5- previous myomectomy reaching the endometrial cavity. (Increases risk of rupture uterus) 7- patient refuse to participate or inability to consent. (patient's right to refuse).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study uses a transvaginal ultrasound to look at something called the 'cervical sliding sign' — can you explain what that means and whether this type of ultrasound assessment is something I'd normally have during an induction, or if it's specific to this trial?
2The trial is measuring things like how long it takes to go from induction to active labor and how I end up delivering — does participating in this study mean my labor management would be any different from standard care, or would the ultrasound just be used for research purposes?
3Since this trial's recruitment status is listed as unknown, do you know if it's actually still enrolling patients, and if not, is there another study or clinical pathway using the cervical sliding sign that I might be able to access?
4The study seems focused on predicting outcomes of labor induction — if the cervical sliding sign suggests my cervix may not respond well to induction, would that information actually change the decisions my care team makes, or would it only be used for research data?
5Are there standard methods already used to assess my cervix before induction, like a Bishop score or cervical length measurement, and how does the cervical sliding sign compare to those in terms of helping guide my care?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.